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Introduction
Medicinal plant products can be used as medicines by 
majority of cultures all around the world (e.g. Indian and 
Chinese medicines) and provide a source of new drugs 
to protect human beings against several diseases (1,2). 
These activities are due to the presence of various primary 
(carbohydrates, protein, lipids, etc) and secondary (flavo-
noids, glycosides, terpenoids, saponin, phenolics, etc) me-
tabolites present in medicinal plants (3). According to the 
World Health Organization (WHO) more than 80% of the 
world’s population still uses or relies on various tradition-
al medicines from plant products against various infec-
tious diseases, as one of their primary health care needs. 
Meanwhile, the majority of new drugs (70%) introduced 
in all over the world are derived from natural products, 
primarily from plants. Studying medicinal plants helps to 
understand their properties with reference to toxicity and 
protect humans and animals from natural poisons (1,4). 
There are approximately 5 lakh plant species occurring 
worldwide of which only 1% has phytochemically been 
explored with a great prospective for discovering novel 
bioactive compounds (1,2).
Butea frondosa (commonly known as palas; family 
Fabaceae), is a medicinal plant growing all over India with 
various medicinal purposes i.e. flowers (for fever, thirst 
and diarrhea); decoction of bark (for bleeding piles); paste 
seeds (for skin diseases, edema and eye diseases) (5,6). In 
contrast, palasonin (alkaloid) extracted from the seeds 
show anthelmintic effect especially in roundworm infes-
tations (e.g. Ascaris lumbricoides). Recently, new alkaloids, 
namely butrin and isobutrin have been reported in flow-
ers of B. frondosa (7,8). In view of this, a small amount 
of work has been done with respect to immunopharma-
cological activities. In this study, we focused on aqueous 
extracts of B. frondosa leaves for determining their anti-
inflammatory and anti-microbial activities in infected and 
non-infected whole human blood against specific vaccine 
antigen (HBsAg).
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Introduction:  Butea frondosa has been suggested to be very useful in treating inflammatory 
diseases but no scientific investigation has been done in such direction. In this study the anti-
inflammatory and anti-microbial activities of leaves aqueous extract of B. frondosa were 
determined in infected and non-infected human whole blood against specific vaccine antigen, 
HBsAg.
Methods: In order to explore the anti-inflammatory and anti-microbial activities of B. frondosa 
(0.5–0 mg/mL; 50 µl), infected (virally) and non infected (control) human whole blood samples 
were stimulated with hepatitis B vaccine containing surface antigen (HBsAg, 20 µg/mL;10 µl) in 
order to determined its blood counts and proliferation assay.
Results: Aqueous leaves extract of B. frondosa (10 mg/mL; 50 µl) containing HBsAg inhibited the 
percentage count of monocytes as well as granulocytes population in both cases. In addition, this 
aqueous extract also reduced its proliferation rate at higher doses.
Conclusion: Aqueous leaves extract of B. frondosa possesses both anti-inflammatory and 
antimicrobial activities and might be used for these purposes.
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Materials and methods
Collection of fresh leaves of B. frondosa
Fresh leaves of B. frondosa were collected from the udyan 
of Vidya Pratishthan’s School of Biotechnology during the 
month of August 2015. They were then dried in a shady 
area and prepared in finely powdered form. 
Phytochemical investigation 
Five grams of above powder was macerated with mortar 
and pestle and then dissolved in phosphate buffered saline 
(PBS) (pH 7.2; 50 mL). The aqueous extracts were filtered 
and used to determine the presence of secondary me-
tabolites. The phytochemical investigation of the aqueous 
extracts was carried out as per standard methods and re-
vealed qualitatively the presence of phenolic compounds, 
flavonoids (by alkaline reagent test), saponin (by foam 
test), terpenoids (by acetic anhydride test) and glycosides. 
In addition, thin layer chromatography of the aqueous 
extract was performed using n butanol: acetic acid: wa-
ter (5:3:2). The observed spots were then visualized using 
anisaldehyde-sulphuric acid reagent.
Human blood samples and estimation of lymphocytes, 
monocytes and granulocytes count using flow cytometer
Immunopharmacological studies were done using non-
infected and infected EDTA anti-coagulant human blood 
samples (2-3 mL) collected from Mangal Pathology labo-
ratory, Baramati.
To determine the effect of aqueous extracts of B. frondosa 
on whole human blood with various doses (0.5 to 30 mg/
mL, 100 µL), pertaining to lymphocytes, monocytes and 
granulocytes count, were suspended in a stream of fluid 
using flow cytometry. In this study, EDTA infected and 
non-infected bloods (50 µL) were divided into two sepa-
rate sets i.e. each exposed to various doses of aqueous 
extracts of B. frondosa. The samples were then incubated 
at 37°C for 2 hours. After centrifugation, the supernatant 
was separated out and washed with PBS. Finally, the pel-
lets were dissolved in PBS and observed through flow cy-
tometry. Data acquisition of 10 000 events representing 
different phenotypes was analyzed using CellQuest soft-
ware (9,10).
Lymphocyte proliferation assay
Lymphocytes (106 cells/mL) of infected and non-infected 
samples of whole human blood were plated in 96-well 
flat = bottom plates (or tissue culture flasks) and incubated 
in the presence of hepatitis B vaccine (HBsAg, 20 µg/mL; 
10 µL) along with serial dilutions of aqueous extracts of 
B. frondosa (0.5-10 mg/mL, 50 µL) at 37°C for 48 hours. 
After incubation, the 96-well flat-bottom plates were cen-
trifugated (at 3000 rpm for 8 minutes). The supernatant 
(100 µL) was discarded and then added to an equal vol-
ume of fresh medium. The cells were then treated with 
20 µL of MTT solution (5 mg/mL) and incubated for 4 
hours. Again, the 96-well flat-bottom plates were spinned 
or centrifuged at 1500 rpm for 4 minutes with discard-
ing the supernatant. 100 µL of DMSO solution was then 
added to the formazon crystals and the absorbance at 570 
nm was measured using ELISA Reader (11,12).
Statistical analysis
One-way analysis of variance (ANOVA) tests (Bonferroni 
multiple comparison tests) were performed. All values 
were mentioned as mean ± standard error (SE). 
Results
Effect of B. frondosa on human blood counts
The effect of aqueous extracts of B. frondosa on infected 
and non-infected whole human blood, pertaining to 
lymphocytes, monocytes and granulocytes count using 
HBsAg, was shown in Figure 1. As seen in both cases 
and at higher doses (10 mg/mL, 100 µL), there was an in-
crease of the monocytes as well as granulocytes count as 
compared to the control, but at the same time an increase 
in the number of lymphocytes. From the data obtained, 
it appears that aqueous extracts of B. frondosa have anti-
inflammatory as well as anti-microbial activities.
Effect of B. frondosa on lymphocyte proliferation assay
The effect of aqueous extracts of B. frondosa (0.5 to 10 mg/
mL, 50 µL) on proliferation assay using human lysed in-
fected and non-infected whole human blood along with 
HBsAg was shown in Figure 2. The results show that 
the aqueous extracts at higher doses (10 mg/mL, 50 µL) 
caused a decline in the proliferation rate as compared to 
the control. Overall the data obtained may confirm the in-
flammatory as well as anti-microbial activities of the aque-
ous extracts of B. frondosa.
Discussion
In recent times, focus on medicinal plant research (e.g. B. 
frondosa) has increased all over the world and a large body 
of evidence has collected to show immense potential of 
this medicinal plant used by various traditional systems. 
This study probably for the first time reveals the aqueous 
leaves extract of B. frondosa for its anti-inflammatory and 
antimicrobial activities. These activities were evaluated 
using whole human blood (infected and non-infected) 
and tested against hepatitis B vaccine containing sur-
face antigen (HBsAg) pertaining to whole human blood 
counts (lymphocytes, monocytes and granulocytes count) 
and proliferation assay. The results showed that B. frondo-
sa can decrease the count of monocytes as well as granu-
locytes including proliferation rate (at higher doses and 
in both cases i.e. infected and non-infected whole blood 
containing HBsAg). The significant anti-inflammatory 
and antimicrobial activities shown by the aqueous leaves 
extract of B. frondosa may be linked to flavonoids, ter-
penoids, glycosides and phenolics found qualitatively in 
the phytochemical screening. It is well known that flavo-
noids have inhibitory effects on enzymes and production 
of chemical mediators and phenolics and terpenoids can 
interfere with several components of the inflammatory 
cascade. 
The findings of the current study were confirmed through 
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flow cytometry and they provide some information re-
lated to the immune system. Nowadays the use of flow 
cytometry has grown qualitatively and quantitatively to 
determine the total cellular immune response against 
various antigens (13,14). The flow cytometric results ob-
tained from the present study clearly indicate that aque-
ous leaves extract of B. frondosa have a declining effect in 
monocytes and granulocytes count (at higher doses and in 
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                     Fig.1. Effect of aqueous leaves extract of Butea frondosa on human whole blood (infected and non infected) using flow   cytometry i.e. 
Forward scatter (FSC) and side scatter (SSC). Data acquisition of 10000 events and fraction or separation of cell populations representing forward and 
side scatter using Cell quest software. R1, R2 and R3 denote lymphocytes, monocytes and granulocytes count.
igure 1. Effect of aqueous leaves extract of Bute  frondosa on human whole blood (infected and non-inf cted) using flow   cytometry i.e. 
forward scatter (FSC) and ide scatter (SSC). Data acquisition f 10 000 events a fraction or separation of cell populations representing 
forward and side scatter using Cell quest software. R1, R2 and R3 denote lymphocytes, monocytes and granulocytes count.
Figure 2. Effect of aqueous leaves extract of Butea frondosa on 
human whole blood using HBsAg. Lysed whole human blood 
(106 cells/mL, 100 µL) were cultured in triplicates in 96-well 
tissue culture plate along with various doses of aqueous leaves 
extract (0.5-10 mg/mL; 50 µL) in complete RPMI 1640 medium 
in presence of HBsAg (20 µg/mL; 10 µL). Proliferation was 
measured by MTT assay. Values are expressed as mean ± SE. 
The absorbance at 570 nm was measured using ELISA reader.
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both cases i.e. infected and non infected blood) stimulated 
with HBsAg, as compared to the control. The data repre-
sents that B. frondosa have anti-inflammatory as well as 
anti-microbial activities.
To estimate anti-proliferative activity of aqueous leaves 
extract of B. frondosa further immunopharmacological 
studies were done by lysing whole human blood (infected 
and non-infected) and lymphocyte proliferation assay us-
ing HBsAg. The capacity of aqueous leaves extract is to 
inhibit T cell immunity with respect to HBsAg (specific 
antigen). This can be shown by the reduction of lympho-
cyte proliferation response. The results indicate that the 
aqueous leaves extract of B. frondosa could significantly 
decrease the activation potential of T cells in lysed whole 
human blood. Overall, the data suggests that the aqueous 
leaves extract of B. frondosa show anti-inflammatory as 
well as anti-microbial activities.
Conclusion
This study suggests that the aqueous leaves extract of B. 
frondosa significantly inhibits the production of mono-
cytes as well as granulocytes count including proliferation 
in both infected and non infected whole human blood. 
Further investigations of the aqueous leaves extract should 
be done through in vivo assessment for immunopharma-
cological studies in mice models with identification of the 
major active components responsible for anti-microbial 
and anti-inflammatory activities. 
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